Considering the previously discussed speech–motor-based difficulties in FXS and FXTAS, this suggests that FMR1-related molecular-genetic variation may contribute to rhythmic differences in speech, likely mediated by subclinical variation in speech–motor control. This evidence concerns the gene FMR1 and fragile X-associated tremor/ataxia syndrome.